Biogen
E3807
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
Aliases (5)
- Avonex ×1
- Biogen Idec ×1
- Biogen Inc. ×1
- Biogen Netherlands B.V. ×1
- NASDAQ:BIIB ×1
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
→
pharmaceutical company → public company → |
| areaServed | worldwide → |
| collaboratesWith |
Eisai
→
Ionis Pharmaceuticals → Genentech →
surface form: "Roche"
|
| country |
United States of America
→
surface form: "United States"
|
| focusesOn |
Alzheimer's disease
→
amyotrophic lateral sclerosis → multiple sclerosis → neurodegenerative diseases → neurological diseases → spinal muscular atrophy → |
| foundedBy |
Charles Weissmann
→
Heinz Schaller → Kenneth Murray → Nils Norman → Phillip A. Sharp →
surface form: "Phillip Allen Sharp"
Walter Gilbert → |
| foundedIn |
1978
→
Geneva → |
| hasKeyTherapeuticArea |
ALS
→
Alzheimer's disease → Parkinson's disease → multiple sclerosis → spinal muscular atrophy → |
| hasNotableDrug |
Spinraza
→
Tecfidera → Tysabri → |
| hasProduct |
Aduhelm
→
Biogen →
surface form: "Avonex"
Fampyra → Leqembi → Plegridy → Spinraza → Tecfidera → Tysabri → Vumerity → |
| hasResearchArea |
immunology
→
neuroscience → rare diseases → |
| headquartersLocation | Cambridge, Massachusetts → |
| industry |
biotechnology
→
pharmaceuticals → |
| specializesIn |
biologic therapies
→
monoclonal antibodies → small-molecule drugs → |
| tradedAs |
Biogen
→
surface form: "NASDAQ:BIIB"
|
Referenced by (28)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form: "Biogen"
this entity surface form: "Biogen Inc."
this entity surface form: "Biogen Idec"
this entity surface form: "Avonex"
this entity surface form: "Biogen Netherlands B.V."